{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:28:54Z","timestamp":1790051334318,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":3474,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fonds voor Wetenschappelijk Onderzoek Vlaanderen","award":["G.0607.09"],"award-info":[{"award-number":["G.0607.09"]}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1111\/jth.12255","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:19:35Z","timestamp":1372637975000},"page":"2-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"S1","title":["Animal models for thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"11","author":[{"given":"K.","family":"Vanhoorelbeke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.F.","family":"De Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12255_bb0010","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1111\/jth.12255_bb0020","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12255_bb0025","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0030","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2011-02-306597","article-title":"Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor","volume":"118","author":"Crawley","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0035","doi-asserted-by":"crossref","first-page":"36361","DOI":"10.1074\/jbc.M111.271890","article-title":"Local elongation of endothelial cell\u2010anchored von Willebrand factor strings precedes ADAMTS13 protein\u2010mediated proteolysis","volume":"286","author":"De Ceunynck","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12255_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MAT.0b013e31824363e7","article-title":"von Willebrand factor, shear stress, and ADAMTS13 in hemostasis and thrombosis","volume":"58","author":"Tsai","year":"2012","journal-title":"ASAIO J"},{"key":"10.1111\/jth.12255_bb0045","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/asheducation.V2012.1.610.3798654","article-title":"Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura","volume":"2012","author":"Kremer Hovinga","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/jth.12255_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/humu.21143","article-title":"ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura","volume":"31","author":"Lotta","year":"2010","journal-title":"Hum Mutat"},{"issue":"Suppl 1","key":"10.1111\/jth.12255_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1538-7836.2011.04341.x","article-title":"Natural history of Upshaw\u2010Schulman syndrome based on ADAMTS13 gene analysis in Japan","volume":"9","author":"Fujimura","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1751-553X.2009.01159.x","article-title":"Berend Houwen Memorial Lecture: ISLH Las Vegas May 2009: the pathogenesis and management of thrombotic microangiopathies","volume":"31","author":"Scully","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.12255_bb0065","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/j.1538-7836.2011.04399.x","article-title":"Polymorphisms and mutations of ADAMTS13 in the Japanese population and estimation of the number of patients with Upshaw\u2010Schulman syndrome","volume":"9","author":"Kokame","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.2004.05217.x","article-title":"von Willebrand factor cleaving protease (ADAMTS\u201013) and ADAMTS\u201013 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura","volume":"127","author":"Peyvandi","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12255_bb0075","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood-2003-05-1616","article-title":"Nonneutralizing IgM and IgG antibodies to von Willebrand factor\u2010cleaving protease (ADAMTS\u201013) in a patient with thrombotic thrombocytopenic purpura","volume":"102","author":"Scheiflinger","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1160\/TH04-05-0301","article-title":"The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura","volume":"93","author":"Luken","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0085","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","article-title":"Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura","volume":"95","author":"Zheng","year":"2010","journal-title":"Haematologica"},{"key":"10.1111\/jth.12255_bb0090","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1538-7836.2011.04307.x","article-title":"Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura","volume":"9","author":"Pos","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/beha.2001.0142","article-title":"Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor\u2010cleaving protease","volume":"14","author":"Furlan","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/jth.12255_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0038-1646169","article-title":"The Weibel\u2010Palade body: the storage granule for von Willebrand factor and P\u2010selectin","volume":"70","author":"Wagner","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0110","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2005010086","article-title":"Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jth.12255_bb0115","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI26007","article-title":"Shiga toxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13\u2010deficient mice","volume":"115","author":"Motto","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12255_bb0120","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2005-07-2765","article-title":"Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura","volume":"107","author":"Banno","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0125","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2141.2008.07515.x","article-title":"Pregnancy\u2010induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw\u2010Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients","volume":"144","author":"Fujimura","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12255_bb0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)80964-2","article-title":"Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage\u2010specific expression of a glycosyltransferase","volume":"96","author":"Mohlke","year":"1999","journal-title":"Cell"},{"key":"10.1111\/jth.12255_bb0135","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.20080130","article-title":"ADAMTS13: a new link between thrombosis and inflammation","volume":"205","author":"Chauhan","year":"2008","journal-title":"J Exp Med"},{"key":"10.1111\/jth.12255_bb0140","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS\u201013 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2012-07-442285","article-title":"Unwinding the von Willebrand factor strings puzzle","volume":"121","author":"De Ceunynck","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0150","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1538-7836.2010.04008.x","article-title":"The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet\u2010decorated VWF strings in vivo","volume":"8","author":"De Maeyer","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.20051732","article-title":"Systemic antithrombotic effects of ADAMTS13","volume":"203","author":"Chauhan","year":"2006","journal-title":"J Exp Med"},{"key":"10.1111\/jth.12255_bb0160","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1182\/blood-2007-09-110700","article-title":"Functional imaging of shear\u2010dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions","volume":"111","author":"Shida","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0165","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1182\/blood-2008-07-169359","article-title":"The distal carboxyl\u2010terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation","volume":"113","author":"Banno","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0170","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1182\/blood-2008-08-173021","article-title":"Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell\u2010mediated gene therapy","volume":"113","author":"Laje","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/mt.2008.223","article-title":"Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes","volume":"17","author":"Niiya","year":"2009","journal-title":"Mol Ther"},{"key":"10.1111\/jth.12255_bb0180","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1182\/blood-2009-02-201749","article-title":"ADAMTS13's tail tale","volume":"113","author":"Vanhoorelbeke","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0185","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1538-7836.2012.04822.x","article-title":"ADAMTS13 reduces VWF\u2010mediated acute inflammation following focal cerebral ischemia in mice","volume":"10","author":"Khan","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0190","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1182\/blood-2009-03-213264","article-title":"von Willebrand factor\u2010cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke","volume":"114","author":"Zhao","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0195","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2009-06-230110","article-title":"ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion","volume":"115","author":"Fujioka","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0200","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/STROKEAHA.111.628867","article-title":"von Willebrand factor: an emerging target in stroke therapy","volume":"43","author":"De Meyer","year":"2012","journal-title":"Stroke"},{"key":"10.1111\/jth.12255_bb0205","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1182\/blood-2012-06-439935","article-title":"Protective anti\u2010inflammatory effect of ADAMTS13 on myocardial ischemia\/reperfusion injury in mice","volume":"120","author":"De Meyer","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0210","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood-2012-06-440255","article-title":"ADAMTS13 deficiency exacerbates VWF\u2010dependent acute myocardial ischemia\/reperfusion injury in mice","volume":"120","author":"Gandhi","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0215","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2011-09-376202","article-title":"ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice","volume":"119","author":"Gandhi","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0220","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/ATVBAHA.112.247262","article-title":"Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model","volume":"32","author":"Jin","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12255_bb0225","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood-2010-02-271957","article-title":"Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13\u2010deficient mice","volume":"116","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0230","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood-2007-08-108571","article-title":"The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis","volume":"111","author":"Chauhan","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0235","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2011-09-380535","article-title":"A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13","volume":"119","author":"Schiviz","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0240","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2010-04-280479","article-title":"Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)","volume":"116","author":"Feys","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0245","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1538-7836.2006.01833.x","article-title":"ADAMTS\u201013 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences","volume":"4","author":"Feys","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0250","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.2174\/138161207781662867","article-title":"Inhibition of platelet glycoprotein Ib and its antithrombotic potential","volume":"13","author":"Vanhoorelbeke","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1111\/jth.12255_bb0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/187152909787581327","article-title":"von Willebrand factor: drug and drug target","volume":"9","author":"De Meyer","year":"2009","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1111\/jth.12255_bb0260","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V77.1.113.113","article-title":"Studies on anti\u2010von Willebrand factor (vWF) monoclonal antibody NMC\u20104, which inhibits both ristocetin\u2010 and botrocetin\u2010induced vWF binding to platelet glycoprotein Ib","volume":"77","author":"Fujimura","year":"1991","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0265","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1182\/blood-2012-04-421248","article-title":"Inhibition of von Willebrand factor\u2010platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons","volume":"120","author":"Feys","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0270","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2012-04-420943","article-title":"Evaluation of efficacy and safety of the anti\u2010VWF Nanobody ALX\u20100681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura","volume":"120","author":"Callewaert","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.transci.2012.03.027","article-title":"The TITAN trial \u2010 Assessing the efficacy and safety of an anti\u2010von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura","volume":"46","author":"Holz","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"10.1111\/jth.12255_bb0280","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/gt.2009.98","article-title":"Adenoviral\u2010mediated gene transfer restores plasma ADAMTS13 antigen and activity in ADAMTS13 knockout mice","volume":"16","author":"Trionfini","year":"2009","journal-title":"Gene Ther"},{"key":"10.1111\/jth.12255_bb0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1160\/TH05-12-0817","article-title":"A common origin of the 4143insA ADAMTS13 mutation","volume":"96","author":"Schneppenheim","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0290","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.12255_bb0295","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1160\/TH12-01-0046","article-title":"ADAMTS13 exerts a thrombolytic effect in microcirculation","volume":"108","author":"Crescente","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0300","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1538-7836.2011.04224.x","article-title":"Recombinant ADAMTS13 normalizes von Willebrand factor\u2010cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies","volume":"9","author":"Plaimauer","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0305","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1160\/TH11-02-0069","article-title":"A dose ranging phase I\/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura","volume":"106","author":"Jilma\u2010Stohlawetz","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12255_bb0310","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI41062","article-title":"N\u2010acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Invest"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12255","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622051479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622051479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12255\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:05:26Z","timestamp":1761534326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622051479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":61,"alternative-id":["S1538783622051479"],"URL":"https:\/\/doi.org\/10.1111\/jth.12255","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models for thrombotic thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}